We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.875 | 5.75 | 6.00 | 5.875 | 5.75 | 5.88 | 602,490 | 15:20:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -1.31 | 6.76M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/2/2021 09:27 | FYI Yourgene Health. Whispers Contract/s "Done Deal"..... Dan x | daniel levi bmd | |
19/2/2021 09:07 | Could happen anytime....that's the beauty of shares! | hazl | |
19/2/2021 08:46 | what if we get a cheeky RNS this afternoon !! not speculating tho .. | pal44 | |
18/2/2021 19:39 | rayj118 Feb '21 - 19:11 - 5026 of 5027 (Filtered) Ahhhh that's better :) | hooded claw | |
18/2/2021 19:15 | Any1 seen Amarilllio kmut | professor_az | |
18/2/2021 19:11 | I think tomorow we will finish on 134, what a massive rise!! Taking in the money now guys!! Excited :) | rayj1 | |
18/2/2021 17:57 | Thanks for your posts earlier ambiorix and hooded claw. I have been on the boards little today. Great info in 5006/8. | hazl | |
18/2/2021 15:40 | The company have got rid of any convertible loans,have a fairly outstanding product....certainly one that Beckman Coulter like.... and are now entering the commercial phase what more would you want? Drops today are across the board. | hazl | |
18/2/2021 15:37 | That was last year! You are not looking back that far are you pal? 2015 it was 300p. | hazl | |
18/2/2021 15:24 | I aggre Losses, it is a bit crazy on prices today. 2 buys for every 1 sell. And down 6.25% ???? | beercapafn | |
18/2/2021 14:19 | This was 300p back in 2015 without all these recent advancements. | hazl | |
18/2/2021 13:13 | Still got news to come onPOC testIndian approval WHO approval FDA EUA for covid With BC behind them anything could be released at anytime now. | blackvulture | |
18/2/2021 12:33 | What's going on.? Can't buy any or normal quote or in exchange! | losses | |
18/2/2021 12:26 | Can't buy a single share at the moment online. | losses | |
18/2/2021 11:47 | Sale figures wont come after a week, will they? | neo26 | |
18/2/2021 09:37 | Absolutely swerves. The headless chickens will continue to be nervous but you just have to realise you can rely on a company the size of BC to deliver substantial sales. I've run medical sales, trust me, these sales guys on the ground will be chomping at the bit to sell something like this. Bonuses all round! | jbravo2 | |
18/2/2021 09:36 | rayj118 Feb '21 - 08:38 - 5010 of 5013 0 0 0 Wtf!! This is all the way down now to 100 :( =============== Sell up and go then if you believe that. | hooded claw | |
18/2/2021 09:34 | When figures come this could double quickly | swerves1 | |
18/2/2021 09:15 | Just surprised on the big drop! | rayj1 | |
18/2/2021 09:11 | PAYtience. Cant expect figures straight away. Only signed deal a couple of weeks ago. Its a business. I am sure GDR have have invoiced BC. They will settle the balance end of the month I assume | rv2 | |
18/2/2021 08:38 | Wtf!! This is all the way down now to 100 :( | rayj1 | |
18/2/2021 08:38 | Well no sales figures published what do we expect after the hype on sales come on we need to see proper sales figures to have confidence here | pal44 | |
18/2/2021 08:30 | Hello again Hazl... and all other interested in... This is the actual list of covid related european tenders. Look for diagnostics. By the way, there could be one for Vectura to, Germany has a tender for Tiotropiumbromide, for which Vectura has a generic version (of Spiriva) | ambiorix1 | |
18/2/2021 08:21 | Wow..looks like a lot not in it for the long run. | rv2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions